WebJul 14, 2024 · The Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT) trial in patients with an elevated triglyceride level reported a resounding 25% relative reduction in major adverse cardiovascular events with icosapent ethyl compared with placebo (NEJM JW Cardiol Jan 2024and N Engl J Med2024; 380:11). WebJan 5, 2024 · In the global phase 3, randomized, double blind, placebo-controlled Semaglutide Treatment Effect in People with Obesity (STEP1) trial, Wilding and colleagues evaluated whether semaglutide (2.4 mg once weekly) along with lifestyle intervention resulted in weight loss in participants with either a body mass index (BMI) ≥30 or BMI ≥27 …
Jordi Riera on Twitter: "Important publication #ECPR. The …
WebApr 5, 2024 · The INCEPTION trial is a multicenter, randomized controlled trial that will explore extracorporeal cardiopulmonary resuscitation (ECPR) in patients in refractory out … WebJul 11, 2015 · A global inception cohort study Maurizio Cecconi, Christoph Hofer, Jean-Louis Teboul, Ville Pettila, Erika Wilkman, Zsolt Molnar, Giorgio Della Rocca, Cesar Aldecoa, Antonio Artigas, Sameer Jog, Michael Sander, Claudia Spies, Jean-Yves Lefrant & Daniel De Backer on behalf of the FENICE Investigators and the ESICM Trial Group fmg architects reston va
Intramuscular versus Intravenous Therapy for Prehospital
WebA monthly digital journal, NEJM Evidence offers a behind-the-scenes view of clinical trials that enables readers to develop a deeper understanding of the statistical methods used in … WebMar 9, 2024 · Basel, March 9, 2024 — Novartis today announced that The New England Journal of Medicine (NEJM) published data showing the Phase III MONALEESA-2 trial for Kisqali ® (ribociclib) plus letrozole demonstrated a statistically significant improvement in overall survival. WebFeb 27, 2024 · The INCEPTION trial was a multicentre, randomised, unblinded, parallel-group, investigator-initiated clinical trial Setting 10 cardiosurgical centres and 12 … fm garage sale facebook